Quality of Life and its Relationship with Perceived Stigma among Opioid Use Disorder Patients: An Exploratory Study

Singh, Swarndeep; Kumar, Saurabh; Sarkar, Siddharth; Balhara, Yatan Pal Singh

doi:10.4103/ijpsym.ijpsym_171_18

Cited by 27 publications

(25 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Stigma is a sociocultural phenomenon in which specific social groups are devalued, rejected, and excluded on the basis of a socially discredited health condition 7 . Public stigma occurs when the general population endorses stereotypes about individuals with substance use disorder and chooses to discriminate against these persons.…”

mentioning

confidence: 99%

Community Attitudes Toward Opioid Use Disorder and Medication for Opioid Use Disorder in a Rural Appalachian County

Beachler

Zeller

Heo

et al. 2020

The Journal of Rural Health

View full text Add to dashboard Cite

To evaluate community attitudes concerning opioid use disorder (OUD) and medication for opioid use disorder (MOUD) in a rural community, and to plan educational initiatives to reduce stigma surrounding OUD and treatment. Methods: Dissemination of a 24-question survey to people living in a rural community followed by comparative analysis of survey results between 2 groups classified by recognition of OUD as a real illness. Findings: Three hundred sixty-one individuals responded. Overall, 69% agreed that OUD is a real illness. Respondents recognizing OUD as a real illness were less likely to agree that individuals with OUD are dangerous (P = .014), more likely to agree that MOUD is effective (P < .001), that individuals with OUD should have the same right to a job (P < .001), and that naloxone should be administered for every overdose every time (P = .002). Conclusions: Significant stigma exists toward individuals with OUD in rural communities, and recognizing OUD as a real illness is associated with less stigmatizing attitudes and better understanding of MOUD. Further study should focus on how to effectively convince communities that OUD is a real illness.

show abstract

mentioning

confidence: 99%

Community Attitudes Toward Opioid Use Disorder and Medication for Opioid Use Disorder in a Rural Appalachian County

Beachler

Zeller

Heo

et al. 2020

The Journal of Rural Health

View full text Add to dashboard Cite

show abstract

“…In addition, there is stigma and discrimination from the community in general, and even health and social service providers. [15,31,32]. This complexity is not new to OST services, but how to respond to build optimism, resilience, and agency in participants to improve QoL and reduce psychological distress is challenging, especially in resource poor settings.…”

Section: Discussionmentioning

confidence: 99%

“…Drug dependence lowers the QoL with impact on all domains which are psychological, physical, social, and emotional domains [13]. Higher levels of perceived stigma and discrimination, especially in relation to injection drug use, are also associated with higher psychological distress, unhealthy behaviors and signi cantly poorer QoL [14,15].…”

Section: Introductionmentioning

confidence: 99%

“…The use of opiates, such as heroin, and synthetic opioids such as oxycodone, tramadol, fentanyl and buprenorphine have been of concern in many countries [1,10,15]. However, resource poor countries often face greater di culties in addressing these diverse but entangled issues, especially where there is civil unrest, armed con ict, corruption, competing health needs, such as infant and maternal health, clean water, and pandemics.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Psychological Distress and Quality of Life Among Opioid Substitution Therapy Participants with Histories of Injecting and Non-Injecting: A Cross-Sectional Study in Kathmandu, Nepal

Pant

Thapa

Howard

et al. 2022

Preprint

View full text Add to dashboard Cite

Background: Opioid use is a serious public health problem in Nepal. People who use opioids can experience severe psychological distress over time along with poor quality of life. Opioid substitution therapy (OST) is central in treating opioid dependence. This study aimed to examine factors associated with quality of life and severe psychological distress among OST therapy participants in the Kathmandu valley, Nepal and compare those who had injected opioids prior to OST and those who did not inject.Methods: A cross-sectional study was conducted with 231 participants proportionately allocated across five OST sites in the Kathmandu Valley. They were administered a semi-structured questionnaire, the Nepalese versions of the Kessler 6 psychological distress scale and World Health Organization Quality of Life (WHOQOL-BREF). Univariate and multivariate analyses were used to elicit associations between severe psychological distress, quality of life, and independent variables. Results: Of the participants 92% were male and about half were injecting drug users. Severe psychological distress was found in about one in four participants, and significantly more prevalent among participants with a history of injecting practices (32.2%) compared to non-injectors (15.9%). Higher mean psychological distress scores were observed among injecting drug users.Those self-reporting a history of psychiatric illnesses were around seven times more likely to have severe psychological distress, and those with history of comorbidity around 1.6 times more likely. In the adjusted linear regression model, injecting drug users were likely to have lower physical quality of life compared to non-injectors. Age was positively associated with better social quality of life. Lower socioeconomic status and a history of self-reported mental illness and attempt to quit substance use, were found to have significantly lower quality of life on all four domains. Conclusions: This study demonstrated that OST participants with a history of injecting drug use were at higher risk of severe psychological distress and lower physical quality of life. In addition to OST, the complex and entangled needs of injecting drug users and non-injectors need to be addressed to improve quality of life and lessen psychological distress and a return to problematic substance use.

show abstract

“…9 Substance use disorders have been demonstrated to negatively impact QoL factors in affected individuals; this encompasses physical and mental health, societal and family functioning, including interpersonal relationships, employment, and residential status. 5,10,11 Quality of life impact is being increasingly recognized as an important consideration in substance use research and clinical practice. 12 While many studies examining the effects of MOUD initiated in the addiction treatment setting have demonstrated positive correlative effects on QoL, it is unclear whether ED-initiated MOUD might have similar impact.…”

mentioning

confidence: 99%

Emergency-Department Initiated Buprenorphine: Impact on Quality of Life Factors

Carroll

Hand

Covington

et al. 2021

Preprint

View full text Add to dashboard Cite

Background: Emergency department (ED)-initiated medications for opioid use disorder (MOUD) have emerged as an effective strategy against the opioid epidemic. Opioid use disorder (OUD) patients engaged in ED-initiated MOUD programs have higher retention in treatment programs and improved outcomes with regard to overdose rates and mortality. It is unclear however, how engagement in ED-initiated MOUD programs might affect quality of life (QoL). We sought to describe demographic characteristics and QoL factors reported by patients engaged in ED-initiated MOUD and referral services. Methods: An ED MOUD-initiation program was launched in July 2019, with subsequent referral to definitive services. Enrolled patients were interviewed at intake, 3-months, and 6-months to ascertain QoL indices via the Government Performance and Results Act (GPRA) measures. Descriptive statistics and Fisher’s Exact were utilized to assess the data. Results: Through 12/2020, 89 participants were enrolled. The majority were white (85.4%), male (61.8%), and between the ages of 25-44 (75.3%). To-date, 31 participants (43.7% eligible) have completed 3-month follow-up and 28 (45.2% eligible) have competed 6-month follow-up. With regards to assessed QoL factors, over half demonstrated significant improvement, including 5 of 7 psychosocial factors, to include satisfaction with personal relationships, QoL self-rating, satisfaction with personal health, energy for everyday life, and satisfaction with self (p <.05). Financial needs met was the only objective QoL factor to demonstrate significant improvement during the follow-up time period. While not significant, homelessness also decreased, specifically 14 (15.7%) identified as homeless at intake as compared to one (3.7%) at 6-month follow-up. Additional trends toward decreased violence exposure and increased employment rates were also noted.Conclusions: In addition to decreasing illicit opioid drug use, maintenance of ED-initiated MOUD may positively impact broad QoL measures.

show abstract

Quality of Life and its Relationship with Perceived Stigma among Opioid Use Disorder Patients: An Exploratory Study

Cited by 27 publications

References 22 publications

Community Attitudes Toward Opioid Use Disorder and Medication for Opioid Use Disorder in a Rural Appalachian County

Community Attitudes Toward Opioid Use Disorder and Medication for Opioid Use Disorder in a Rural Appalachian County

Psychological Distress and Quality of Life Among Opioid Substitution Therapy Participants with Histories of Injecting and Non-Injecting: A Cross-Sectional Study in Kathmandu, Nepal

Emergency-Department Initiated Buprenorphine: Impact on Quality of Life Factors

Contact Info

Product

Resources

About